Skip to main content

Table 4 Treatment-related or fatal serious adverse events

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

SAEs considered related to ASAQ 11
 Asthenia 4
 Vomiting 3
 Extrapyramidal disorders 3
 Dyspnoea 1
Fatal SAEs (all considered unrelated) 24a
 Malaria 8
 Malaria with cough 1
 Anaemia 4
 Anaemia with sepsis 1
 Pneumonia 1
 Diarrhoea with dehydration 1
 Peritonitis 1
 Ascites 1
 Hypoglycaemia 1
 Encephalitis 2
 Febrile convulsions 1
  1. SAE serious adverse events
  2. a22 patients died, two of whom presented two SAEs at the time of death (anaemia with sepsis in one patient and diarrhoea with dehydration in the other). A further patient presented with malaria (serious) and cough (non-serious) at the time of death